Skip to main content
Year archive

Aladdin Healthcare Technologies SE — 2020 filings

All 36 regulatory filings released by Aladdin Healthcare Technologies SE (NMI) in 2020, sourced directly from the official regulator.

36 Filings
2020 Period
2020 filings (36)
Filing Released Lang
Report Publication Announcement 2020
Report Publication Announcement
2020-12-11 English
Aladdin Healthcare Technologies SE reports preliminary figures for financial year 2019 and readjustment of the 2018 financial year figures
Earnings Release FY 2019
2020-12-08 English
DGAP-DD: Aladdin Healthcare Technologies SE english
Director's Dealing
2020-10-21 English
Aladdin Healthcare Technologies completes AI-driven Drug Discovery Platform (AIDD) for Commercial Use in Drug Development
Regulatory Filings
2020-10-08 English
Aladdin Healthcare Technologies will obtain an equity stake in public spinoff No-Age Biotech Inc. at TSX, aimed to combat age-related diseases
M&A Activity
2020-09-24 English
DGAP-DD: Aladdin Healthcare Technologies SE english
Director's Dealing
2020-09-21 English
Aladdin Healthcare Technologies completes Biomedical Knowledge Graph for Commercial use In Drug Development
Regulatory Filings
2020-09-21 English
Aladdin Healthcare Technologies signs with leading Market Maker and Broker for OTCQX Listing in the USA
Regulatory Filings
2020-09-15 English
Aladdin Healthcare Technologies achieves OTCQX listing in the USA
Delisting Announcement
2020-08-31 English
Aladdin Healthcare Technologies validates its proprietary Deep Learning Algorithms that significantly improve Drug Discovery Performance
Regulatory Filings
2020-07-30 English
Aladdin Healthcare Technologies becomes a sponsor of University College London's (UCL) Industry Exchange Network (IXN) Programme
Regulatory Filings
2020-07-28 English
Aladdin Healthcare Technologies develops fully automated deep learning process to detect and distinguish COVID-19 from other diseases from CT images /research study published on IEEE Access
Legal Proceedings Report
2020-07-20 English
Aladdin Healthcare Technologies SE discovers Life-Saving Drug Repurposed for Coronavirus and wins the World's Leading Data Mining Conference Cup
Regulatory Filings
2020-07-02 English
Aladdin Healthcare Technologies SE takes another big step forward in early diagnosis of Alzheimer's Disease: Aladdin gets extensive multimodal data from the largest Dementia platform in the UK
Regulatory Filings
2020-06-17 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-27 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-22 English
Aladdin Healthcare Technologies SE achieves further milestone in COVID-19 drug development: Discovery of 20 new optimized compounds with AI DD platform
Regulatory Filings
2020-05-20 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2020-05-18 English
Aladdin Healthcare Technologies SE wins EUR 1.4 million EU grant with large-scale project 'Dragon' for Coronavirus diagnostics
Regulatory Filings
2020-05-14 English
Aladdin Healthcare Technologies SE promotes drug development with Joint Venture in China - first sales revenues of EUR 120.000 generated
Regulatory Filings
2020-04-30 English
Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer - first sales revenues of EUR 120,000
Regulatory Filings
2020-04-29 English
Aladdin Healthcare Technologies SE: Verzogerung bei der Veroffentlichung des Jahresabschlusses 28. April 2020
Report Publication Announcement
2020-04-28 German
Aladdin Healthcare Technologies SE has launched its Health Risk Assessment Tool to Airbus (India) and Saregama (India)
Regulatory Filings
2020-04-16 English
Aladdin Healthcare Technologies SE: Capital increase against cash contribution with subscription rights and public offer
Capital/Financing Update
2020-04-06 English
DGAP-DD: Aladdin Healthcare Technologies SE english
Director's Dealing
2020-04-02 English
Aladdin Healthcare Technologies SE launches its prototype 'Health Risk Assessment Tool' for COVID-19 in India - The Technology is the basis for worldwide application
Regulatory Filings
2020-03-30 English
Aladdin Healthcare Technologies SE delivers Thermo-Imaging AI System for COVID-19 Coronavirus and Early Virus Mass Detection
Regulatory Filings
2020-03-26 English
Aladdin Healthcare Technologies SE plans listing on trading platform XETRA
Regulatory Filings
2020-03-17 English
Aladdin Healthcare Technologies SE signs MOU with partner in India to validate and distribute COVID-19 diagnosis prototype
Environmental & Social Information
2020-03-16 English
Aladdin Healthcare Technologies SE: Kapitalerhohung gegen Bareinlage mit Bezugsrecht und offentliches Angebot
Capital/Financing Update
2020-03-03 German
Aladdin Healthcare Technologies SE: Kapitalerhohung gegen Bareinlage mit Bezugsrecht und offentliches Angebot
Capital/Financing Update
2020-03-03 German
Aladdin Healthcare Technologies SE has developed a novel prototype application for more accurate real-time diagnosis of COVID-19 Corona Virus.
Regulatory Filings
2020-03-03 English
Aladdin Healthcare Technologies SE: Announces the appointment of Chief Scientific Advisor David C. Rubinsztein
Board/Management Information
2020-02-07 English
Aladdin Healthcare Technologies SE: Announces we have achieved a top five position in Kaggle's Global Data Science Bowl 2019
Regulatory Filings
2020-02-04 English
Aladdin Healthcare Technologies SE: Announces we have developed a prototype A.I powered data analysis platform for brain imaging.
Regulatory Filings
2020-01-16 English
Aladdin Healthcare Technologies SE: release a SAAS prototype for Early Diagnosis of Alzheimer's Disease based on blood test results
Regulatory Filings
2020-01-08 English